Olaparib is a selective poly (ADP-ribose) polymerase inhibitor. However, its clinical application is hindered by low solubility and undesired pharmacokinetic profiles (e.g., relatively short circulation).
Tailoring polymeric micelles for improved olaparib solubility and drug release
- Post author:
- Post published:May 23, 2024
- Post category:uncategorized